Ligand recognition and biased agonism of the D1 dopamine receptor

被引:0
|
作者
Xiao Teng
Sijia Chen
Yingying Nie
Peng Xiao
Xiao Yu
Zhenhua Shao
Sanduo Zheng
机构
[1] Tsinghua University,Tsinghua Institute of Multidisciplinary Biomedical Research
[2] National Institute of Biological Sciences,Key Laboratory Experimental Teratology of the Ministry of Education and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Cheeloo College of Medicine
[3] Graduate School of Peking Union Medical College,Key Laboratory Experimental Teratology of the Ministry of Education and Department of Physiology, School of Basic Medical Sciences, Cheeloo College of Medicine
[4] Shandong University,Division of Nephrology and Kidney Research Institute, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital
[5] Shandong University,undefined
[6] Sichuan University,undefined
来源
Nature Communications | / 13卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Dopamine receptors are widely distributed in the central nervous system and are important therapeutic targets for treatment of various psychiatric and neurological diseases. Here, we report three cryo-electron microscopy structures of the D1 dopamine receptor (D1R)-Gs complex bound to two agonists, fenoldopam and tavapadon, and a positive allosteric modulator LY3154207. The structure reveals unusual binding of two fenoldopam molecules, one to the orthosteric binding pocket (OBP) and the other to the extended binding pocket (EBP). In contrast, one elongated tavapadon molecule binds to D1R, extending from OBP to EBP. Moreover, LY3154207 stabilizes the second intracellular loop of D1R in an alpha helical conformation to efficiently engage the G protein. Through a combination of biochemical, biophysical and cellular assays, we further show that the broad conformation stabilized by two fenoldopam molecules and interaction between TM5 and the agonist are important for biased signaling of D1R.
引用
收藏
相关论文
共 50 条
  • [1] Ligand recognition and biased agonism of the D1 dopamine receptor
    Teng, Xiao
    Chen, Sijia
    Nie, Yingying
    Xiao, Peng
    Yu, Xiao
    Shao, Zhenhua
    Zheng, Sanduo
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [2] Reversal of methamphetamine sensitization by repeated administration of dopamine D1 receptor agonism: Effect on the affinity of dopamine D1 and D2 receptor
    Shuto, Takahide
    Seeman, Philip
    Nishi, Akinciri
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 189P - 189P
  • [3] Molecular Determinants of Biased Agonism at the Dopamine D2 Receptor
    Weichert, Dietmar
    Banerjee, Ashutosh
    Hiller, Christine
    Kling, Ralf C.
    Huebner, Harald
    Gmeiner, Peter
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (06) : 2703 - 2717
  • [4] Dopamine Synthesis and D1 Receptor Agonism are Essential for Resolution of Experimental Lung Fibrosis
    Haak, Andrew
    Caporarello, Nunzia
    Meridew, Jeffrey
    Choi, Kyoung
    Tschumperlin, Daniel
    FASEB JOURNAL, 2021, 35
  • [5] Expression of dopamine D1 receptor in Sf9 insect cells and agonism of l-12-chloroscoulerine on recombinant D1 receptor
    He, Y
    Jin, WQ
    Shen, QX
    Chen, XJ
    Jin, GZ
    ACTA PHARMACOLOGICA SINICA, 2003, 24 (03) : 225 - 229
  • [6] Dopamine Receptor D1 Agonism and Antagonism Using a Field-Effect Transistor Assay
    Park, Seon Joo
    Yang, Heehong
    Lee, Seung Hwan
    Song, Hyun Seok
    Park, Chul Soon
    Bae, Joonwon
    Kwon, Oh Seok
    Park, Tai Hyun
    Jang, Jyongsik
    ACS NANO, 2017, 11 (06) : 5950 - 5959
  • [7] Structural basis of psychedelic LSD recognition at dopamine D1 receptor
    Fan, Luyu
    Zhuang, Youwen
    Wu, Hongyu
    Li, Huiqiong
    Xu, Youwei
    Wang, Yue
    He, Licong
    Wang, Shishan
    Chen, Zhangcheng
    Cheng, Jianjun
    Xu, H. Eric
    Wang, Sheng
    NEURON, 2024, 112 (19)
  • [8] SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C
    Lee, Sang-Min
    Kant, Andrew
    Blake, Daniel
    Murthy, Vishakantha
    Boyd, Kevin
    Wyrick, Steven J.
    Mailman, Richard B.
    NEUROPHARMACOLOGY, 2014, 86 : 145 - 154
  • [10] Dopamine D1 Receptor in Cancer
    Sobczuk, Pawel
    Lomiak, Michal
    Cudnoch-Jedrzejewska, Agnieszka
    CANCERS, 2020, 12 (11) : 1 - 22